Voisin Consulting Life Sciences webinar icon
Webinar

To Go or Not To Go Into Parallel Consultation

Post thumbnail To Go or Not To Go Into Parallel Consultation

Are you wondering about the feasibility of parallel consultation, what sponsors should be aware of, as well as the opportunities and pitfalls of seeking this process? Here is to clarify your doubts with case studies how easy and feasible is the parallel consultation in practice, what should the sponsors be aware of, as well as the opportunities and pitfalls of seeking this process.

Key learning objectives:

Understand the benefits of EMA scientific advice, HTA advice and parallel consultation
Know the alternative options when parallel consultation isn’t applicable or the best choice

Voisin Consulting Life Sciences download icon

Access the full webinar replay now

Fill in the form to download the content
Yes, I would like to receive communications regarding VCLS services and events


Sample of the webinar

To Go or Not To Go Into Parallel Consultation?

Featured Speakers

Gabrielle Nayroles
Gabrielle Nayroles, M.Sc.
Director, Market Access
As a Director in the Market Access team, Gabrielle is responsible for conducting market access analyses and providing recommendations and…
View profile
Delphine Kazancigil thumbnail
Delphine Kazancigil
Pharm.D, M.Sc, Director, Regulatory Science, Drugs & Biologics
Delphine Kazancigil is Director in VCLS’s office in Paris. She is an experienced regulatory science professional who has an in-depth knowledge of the European (EU) legislation and regulatory requirements.Delphine assists clients with her scientific, technical and regulatory expertise in the design of products development plans and associated regulatory and registration strategies. In particular, she has significant experience in writing pediatric investigational plans (PIP), including recommendations on the design of the PIP and in writing orphan drug designation (ODD) applications in the EU